Photo of Richard G. Ziegler

Supply chain finance products have a well-deserved reputation of being fairly low risk propositions.  The majority of facilities are uncommitted, exposures are typically short-term and many counterparties are highly rated and well capitalized.  However, even in this product segment, as the COVID-19 pandemic continues to spread and most developed economies face the real prospect of